Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: ACAN who wrote (29439)	5/13/1999 1:22:00 PM
From: Doug R	Respond to of 79313

Allan, Another point of interest on BJCT: Bioject CEO James O'Shea featured in Wall Street Transcript CEO Forum Web Audio Program NEW YORK--(BUSINESS WIRE)--May 13, 1999--The Wall Street Transcript has placed an audio CEO Forum with James O'Shea of Bioject at twst.com. Available free, the 45 minute program is provided in RealAudio format so users will need the RealPlayer to hear the forum. A link to a free download of RealPlayer is included on the TWST site. Bioject Medical Technologies (Nasdaq:BJCT) is a small cap medical device company, which develops, manufactures and markets a jet injection system for needle-free drug delivery, and also a blood glucose monitoring system for diabetics. Questions are posed by Dr. Alexander Arrow of Wedbush Morgan Securities, and David Wanetick, The Wall Street Transcript moderator. They ask about the technology of Bioject's products, its patents, clinical trials, pain and safety considerations, manufacturing costs, cash burn and financing, major competitors Medi-Ject (Nasdaq:MEDJ) and Minimed (Nasdaq:MNMD), its development partnership with Elan (NYSE:ELN) for glucose monitoring, and its distribution partnership with Hoffman-LaRoche for the needle-free system. The CEO Forum is an audio program that is unique to The Wall Street Transcript. In the same roundtable panel format used for more than 35 years in our publication, the CEO of a company is posed knowledgeable questions about the strategy, vision, market, competition, regulation, growth prospects, new products, financial performance and organization strength of the firm - for the benefit of investors and potential investors. The Wall Street Transcript's CEO Forums are hosted by arrangement with broadcast.com, the leading Internet service for business related audio programs. The program is available free to listeners at twst.com and lasts about 45 minutes. The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors for over 35 years. The Transcript publishes industry roundtables and interviews with Wall Street analysts, money managers, and company CEOs, and is read by top money managers, brokers and individual investors. For information call 212/952-7400, or visit TWST Online at twst.com.